Article Listing - End Of Year Encouraging For US Companies

HUNGARIAN DRUGS "STILL COMPETITIVE"

6 April 1992

Despite the collapse of the Soviet market, Hungarian pharmaceutical companies have succeeded in making up for these lost sales by...

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

New sales and earnings records were achieved in 1991 by American Home Products (Mar-ketletter January 20). The year was said...

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

Despite the enormous size of some Continental European pharmaceutical companies, they are being valued by their respective equity capital markets...

mexican health ministry merges

6 April 1992

In a major shake-up within the Mexican administration, the government is proposing to merge the Ministry of Health with the...

Hib VACCINE LAUNCHED IN FRANCE

6 April 1992

Pasteur Vaccins has launched HIbest, a Hemophilus influenzae type B conjugate vaccine, in France. The product is suitable for...

ICN HUBBER GROUP IN SPAIN

6 April 1992

The ICN Hubber Group is investing 1.7 billion pesetas ($2.2 million) in a new pharmaceutical plant near Barcelona in Spain....

US FDA USER FEES: "THE TIME HAS COME"

6 April 1992

People in the US Food and Drug Administration-regulated industries now recognize that the time has arrived for user fees to...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

TAMOXIFEN OF BENEFIT IN OSTEOPOROSIS?

6 April 1992

A US study looking at the effects of Imperial Chemical Industries' synthetic anti-estrogen Nolvadex (tamoxifen) in post-menopausal women with early-stage...

DRUGS AND SWEDEN'S HEALTH BILL

6 April 1992

Sales of pharmaceutical products in Sweden totaled 10 billion krone ($1.6 billion) in 1990, an increase of 1 billion krone...

Showing 94591-94600 of 95558 articles